Technical Analysis for CANF - Can-Fite Biopharma Ltd Sponsored ADR (Israel)
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 2.04 | -5.56% | -0.12 |
CANF closed down 5.56 percent on Friday, February 26, 2021, on 43 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Down | Down |
| Historical CANF trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 50 DMA | Bearish | 0.00% | |
| 200 DMA Support | Bullish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Fell Below 20 DMA | Bearish | -5.56% | |
| Calm After Storm | Range Contraction | -5.56% | |
| Wide Bands | Range Expansion | -5.56% | |
| Crossed Above 20 DMA | Bullish | -13.56% | |
| Pocket Pivot | Bullish Swing Setup | -13.56% | |
| Calm After Storm | Range Contraction | -13.56% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| 50 DMA Support | 1 day ago | |
| 200 DMA Support | 1 day ago | |
| 60 Minute Opening Range Breakdown | 1 day ago | |
| Down 5% | 1 day ago | |
| Down 3% | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/27/2019
Can-Fite BioPharma, Ltd., a biotechnology company, develops drugs for the treatment of cancer and autoimmune inflammatory diseases. The company principally develops CF101 that is in Phase III study for the treatment of psoriasis; and has completed Phase II study for the treatment of rheumatoid arthritis and glaucoma, as well as completed Phase III study for the treatment of dry eye and Phase I study for the treatment of uveitis. It also develops CF102, which is in Phase II study for the treatment of hepatocellular carcinoma; and CF602 that has completed pre-clinical trial for the treatment of inflammatory diseases. The company was founded in 2000 and is based in Petach Tikva, Israel.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Immunology Treatment Of Cancer Inflammatory Disease Inflammatory Diseases Rheumatoid Arthritis Carcinoma Psoriasis Glaucoma Arthritis Hepatocellular Carcinoma Immunosuppressants Petach Uveitis Biotie Therapies Treatment Of Inflammatory Disease Treatment Of Inflammatory Diseases Treatment Of Psoriasis Immune Inflammatory Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Immunology Treatment Of Cancer Inflammatory Disease Inflammatory Diseases Rheumatoid Arthritis Carcinoma Psoriasis Glaucoma Arthritis Hepatocellular Carcinoma Immunosuppressants Petach Uveitis Biotie Therapies Treatment Of Inflammatory Disease Treatment Of Inflammatory Diseases Treatment Of Psoriasis Immune Inflammatory Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.98 |
| 52 Week Low | 1.15 |
| Average Volume | 1,125,434 |
| 200-Day Moving Average | 1.99 |
| 50-Day Moving Average | 2.06 |
| 20-Day Moving Average | 2.31 |
| 10-Day Moving Average | 2.39 |
| Average True Range | 0.25 |
| ADX | 47.3 |
| +DI | 30.56 |
| -DI | 20.89 |
| Chandelier Exit (Long, 3 ATRs ) | 2.23 |
| Chandelier Exit (Short, 3 ATRs ) | 2.65 |
| Upper Bollinger Band | 2.76 |
| Lower Bollinger Band | 1.85 |
| Percent B (%b) | 0.21 |
| BandWidth | 39.46 |
| MACD Line | 0.06 |
| MACD Signal Line | 0.11 |
| MACD Histogram | -0.0537 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.35 | ||||
| Resistance 3 (R3) | 2.35 | 2.25 | 2.30 | ||
| Resistance 2 (R2) | 2.25 | 2.18 | 2.25 | 2.28 | |
| Resistance 1 (R1) | 2.15 | 2.13 | 2.10 | 2.14 | 2.26 |
| Pivot Point | 2.05 | 2.05 | 2.02 | 2.05 | 2.05 |
| Support 1 (S1) | 1.94 | 1.97 | 1.89 | 1.94 | 1.82 |
| Support 2 (S2) | 1.84 | 1.92 | 1.84 | 1.80 | |
| Support 3 (S3) | 1.74 | 1.84 | 1.78 | ||
| Support 4 (S4) | 1.73 |
